Role of vanadium in treating diabetes

Journal of Trace Elements in Experimental Medicine

Volumn 12, Issue 4, 1999, Pages 393-401

  Sakurai, Hiromu ^a   Fujisawa, Yae ^a   Fujimoto, Seiki ^a   Yasui, Hiroyuki ^a   Takino, Toshikazu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; UNCLASSIFIED DRUG; VANADATE SODIUM; VANADIUM; VANADYL CYSTEINATE; VANADYL DERIVATIVE; VANADYL METHYLPICOLINATE; VANADYL SULFATE;

CONFERENCE PAPER; DRUG DISTRIBUTION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL;

EID: 0033500612     PISSN: 0896548X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-670X(1999)12:4<393::AID-JTRA13>3.0.CO;2-P     Document Type: Conference Paper

References (35)

1. WHO: Diabetes mellitus: Reports of a WHO study group. WHO Technical Report Series 1985;727, 876.
2. Orvig C, Thompson KH, Battell M, McNeill JH. Vanadium compounds as insulin mimetics. In Sigel H, Sigel A, editors. Vanadium and its roles in life: metal ions in biological systems, Vol. 31. New York: Marcel Dekker; 1995, p 575.
3. Sakurai H, Tsuji A. Antidiabetic action of vanadium complexes in animals: blood glucose normalizing effects, organ distribution of vanadium, and mechanism for insulin-mimetic action. In Nriagu JO, editor. Vanadium in the environment, Part 2: health effects. New York: Wiley & Sons; 1998, p 297.
4. 2) coordination mode. In Tracey AS, Crans DC, editors. Vanadium compounds: chemistry, biochemistry, and therapeutic applications. ACS Symposium Series 711. Washington, DC: American Chemical Society, p 344.
5. Sakurai H, Fujisawa Y, Yasui H, Fujimoto S. Orally active vanadyl complexes to treat insulin-dependent and noninsulin-dependent diabetes mellitus. In: 33rd International Conference on Coordination Chemistry: the chemistry of metal ions in everyday life. Florence, Italy, 30 Aug-4 Sept, 1998, Abs p. 614.
6. Lyonnet B, Martz X, Martin E. L'emploi therapeutigue des derives du vanadium. Presse Med 1989; 1:191.
7. Cohen N, Halberstam M, Shilimovich P, Chang CJ, Shamoon H, Rossetti L. Oral vanadyl sulfate improves hepatic and peripheral insulin-sensitivity in patients with non-insulin-dependent diabetes mellitus, J Clin Invest 1995;95:2501.
8. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR. Metabolic effects of sodium metavanadate in human with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab 1995;80:3311.
9. Goldfine AB, Simonson DC, Folli F, Patti M-E, Kahn CR. In vitro and in vivo studies of vanadate in human and rodent diabetes. Mol Cell Biochem 1995;153:217.
10. Halberstam M, Cohen N, Shilimovitch P, Rossetti L, Shamoon H. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes 1996;45:659.
11. Boden G, Chen X, Ruiz J, van Rossum GDV, Turco S. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with noninsulin-dependent diabetes mellitus. Metabolism 1996;45:1130.
12. Chasteen ND. The biochemistry of vanadium. Struc Bonding 1983;53:105.
13. Kustin K, Macara IG. The new biochemistry of vanadium. Comments Inorg Chem 1982;2:1.
14. Rehder D. Inorganic consideration on the function of vanadium in biological systems. In Siegel H, Siegel A, editors. Vanadium and its roles in life: metal ions in biological systems, Vol 31. New York: Marcel Dekker; 1995, p 1.
15. Stern A, Yin X, Tsang S-S, Davison A, Moon J. Vanadium as a modulator of cellular regulatory cascades and oncogene expressions. Biochem Cell Biol 1993;71:103.
16. Hudson FTG. Vanadium: toxicology and biochemical significance. New York: Elsevier; 1964, p 140.
17. Brichard SM, Henguin J-C. The role of vanadium in the management of diabetes. Trends Pharmaco Sci 1995;16:265.
18. Cantley Jr, LC Josepson L, Warner R, Yanagisawa M, Lechene C, Guidotti G. Vanadate is a potent (Na-K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem 1977;252:7421.
19. Sakurai H, Shimomura S, Fukuzawa K, Ishizu K. Occurrence of vanadium ions in serum albumins. Biochim Biophys Acta 1987;924:562.
20. Sakurai H, Nishida M, Kida K, Koyama M, Takada J. Determination and characterization of vanadium ion in serum albumins. Inorg Chim Acta 1987;138:149.
21. Sakurai H, Shimomura S, Fukuzawa K, Ishizu K. Detection of oxovanadium (IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium (V). Biochem Biophys Res Commun 1980;96:293.
22. Nakai M, Watanabe H, Fujisawa C, Kakegawa H, Satoh T, Takada J, Matsushita R, Sakurai H. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds. Biol Chem Bull 1995;18:719.
23. Sakurai H, Tshuchiya K, Nukatsuka M, Sofue M, Kawada J. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J Endocrinol 1990;126:451.
24. Pederson RA, Ramanadham S, Bucham AMJ, McNeill JH. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes 1989;38:1390.
25. Meyerovitch J, Farfel Z, Sack J, Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-induced rats, J Biol Chem 1987;262:6658.
26. Sakurai H, Tshuchiya K, Nukatsuka M, Kawada J, Ishikawa S, Yoshida M, Komatsu M. Insulin-mimetic action of vanadyl complexes. J Clin Biochem Nutr 1990;8:193.
27. Pearson RG. Hard and soft acids and bases. J Am Chem Soc 1963;85:3533.
28. Sakurai H, Hamada Y, Shimomura S, Yamashita S, Ishizu K. Cysteine methylester-oxovanadium (IV) complex, preparation and characterization. Inorg Chim Acta 1980;46:L119.
29. Sakurai H, Taira Z, Sakai N. Crystal structure of an L-cysteine methylester-vanadyl (IV) complex. Inorg Chim Acta 1980;151:85.
30. Watanabe H, Nakai M, Komazawa K, Sakurai H. A new orally active insulin mimetic vanadyl complex: bis(pyrrolidine-N-carbodithioato)oxovanadium (IV). J Med Chem 1994;37:876.
31. Sakurai H, Watanabe H, Tamura H, Yasui H, Matsushita R, Takada J. Insulin-mimetic vanadyl-dithiocarbamate complexes. Inorg Chim Acta 1998;283:175.
32. Sakurai H, Fujii K, Watanabe H, Tamura H. Orally active insulin-mimetic vanadyl complex: bis(picolinate)oxovanadium (IV). Biochem Biophys Res Commun 1995;214:1095.
33. Fujimoto S, Fujii K, Yasui H, Matsushita R, Takada J, Sakurai H. Long-term acting and orally active vanadyl-methylpicolinate complex with hypoglycemic activity in streptozotocin-induced diabetic rats. J Clin Biochem Nutr 1997;23:113.
34. Takechi K, Tamura H, Yamaoka K, Sakurai H. Pharmacokinetic analysis of free radicals by in vivo BCM (blood circulation monitoring)-ESR method. Free Rad Res 1997;26:483.
35. Yasui H, Takechi K, Sakurai H. Metallokinetic analysis on disposition of vanadyl complexes as insulin-mimetics in rats by BCM-ESR method. J Inorg Biochem (in press).